The 2.5mm x 3mm LSM6DSV320X integrates three micro-electromechanical systems (MEMS) sensors, comprising the ±16g and ±320g ...

On a GAAP basis, gross profit margin in the first quarter of 2025 was 48.7%, compared to 54.6% in the fourth quarter of 2024 and 50.5% in the first quarter of 2024. First quarter 2025 GAAP operating ...

In the fiscal year 2024/25, Alstom's adjusted EBIT was €1,177 million, up 18%, equivalent to a 6.4% aEBIT margin, and EBIT before PPA was €831 million. Adjusted net profit was €498 million, net income ...

Q1 2025 Earnings Call Transcript May 12, 2025 FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, ...

Inovio Pharmaceuticals, Inc. ( NASDAQ: INO) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Jennie Willson - IR Jacqui Shea - President & CEO Mike Sumner - Chief Medical Officer Steve Egge - ...

Welcome to FibroGen first quarter 2025 earnings conference call. (Operator Instructions). Please be advised today's conference is being recorded. I would not like to end the conference over to your ...

Detailed price information for Discovery Silver Corp (DSV-T) from The Globe and Mail including charting and trades.

Within the rapidly changing world of online sports betting, BetVisa Bangladesh has become a leading resource for bettors and lovers in the area. This platform has altered the expectations for digital ...

Rigetti Computing, Inc. (Nasdaq: RGTI) ("Rigetti" or the "Company"), a pioneer in full-stack quantum-classical computing, today announced its financial ...

Revenue Increases 18% Year-over-Year Delivers Positive Net Income and $1.3 Million in Operating Cash Flow Increases 2025 Revenue Guidance to $127 Million to $131 Million ...

Silver Palace is a fantastical new ARPG set in the Victorian-inspired metropolis Silvernia, featuring stunning anime-esque visuals powered by Unreal Engine 5 and fast-paced, fluid combat.

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical ...